T. Mcnearney

Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma)

H. Sallam, T. McNearney, Jiande D. Z. Chen, 2006, Alimentary pharmacology & therapeutics.

Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin e synthase 1 inhibitor, with celecoxib

R. Dean, W. Landschulz, A. Regev, 2016, Clinical pharmacology and therapeutics.

Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies

B. Baethge, S. Sairam, T. McNearney, 2003, Clinical Rheumatology.

A proof-of-concept (POC) study including experimental pain models (EPMs) to assess the effects of a CB2 agonist (LY2828360) in the treatment of patients with osteoarthritic (OA) knee pain

L. Arendt-Nielsen, H. C. Hoeck, B. Boulanger, 2013 .